An intrathecal drug delivery system including an intrathecal drug delivery device configured to deliver a fluid containing one or more pharmaceutical agents intrathecally to CSF within a spinal canal of a patient, a deep brain catheter having an elongated body extending from distal end is configured implanted within a deep brain structure of a patient and a proximal end positioned within the subarachnoid space directly adjacent to the brain to provide a passageway via an inner lumen between subarachnoid space and the deep structure. The drug delivery system configured to transport the pharmaceutical agent using diffusion and pulsatile flow of the CSF through the deep brain catheter from the subarachnoid space to the deep brain structure.

A surgical instrument access port assembly and method of use is disclosed. A locking mechanism includes a lock base having an aperture that receives the surgical access port. A locking member has an opening that receives the surgical access port. A ball having a lateral slit is received between the lock base and the locking member. The locking member is rotatable relative to the lock base into a locked position to secure the surgical access port with the ball when the surgical access port is inserted into fascia, and the locking member compresses the lateral slit in the locked position.

A valve assembly (1, 12, 21, 31, 44, 52, 60) includes a hollow tube (2). The valve assembly (1, 12, 21, 31, 44, 52, 60) also includes a first set of one or more valves (3) 5 arranged within the hollow tube (2). The first set of valves (3) is configured to permit sliding passage of a substantially cylindrical object (4). The valve assembly (1, 12, 21, 31, 44, 52, 60) also includes a second set of valves (5) arranged within the hollow tube (2) and spaced apart from the first set of valves to (3) define a chamber. The second set of valves (5) are configured to permit sliding passage of the cylindrical object (4). The 10 valve assembly (1, 12, 21, 31, 44, 52, 60) also includes one or more ultraviolet light sources (10) within the chamber (6) and/or a first port (13) connecting the chamber (6) to the exterior of the hollow tube (2) and configured for connection to a fluid flow path (14) for supply and/or extraction of fluid (19).

The disclosure relates to a subcutaneously implanted port device for establishing access to the vascular system of a patient requiring multiple blood treatments over an extended period of time. The systems, devices and methods disclosed herein may reduce miscannulation, promote intra-session hemostasis, and decrease the incidence of bacteremia and sepsis among other improvements and advantages. The devices include a port with a tapered seat for receiving an access tube, the first tapered seat having a proximal portion, a distal portion, and a conical section extending between the proximal portion and the distal portion; and an interface surface configured to engage a blood vessel or a vascular access catheter. The proximal portion of the tapered seat is configured to receive the access tube therethrough, and the tapered seat creates a mismatch fit with a diameter of the access tube when in use for an increase in flow during treatment.

A vascular access site management system includes a stabilization body and a flow housing that is rotatable relative to the stabilization body. The flow housing may have a flow path extending through it to allow fluids to be introduced into or extracted from a patient via a catheter connected to the vascular access site management system. The vascular access site management system may also include a needle free connector fluidly connected to the flow housing via a section of tubing.

The present technology relates to vascular access devices, systems, and methods configured to monitor a patient's health. In some embodiments, the vascular access device may include a sensing element, and the system of the present technology may be configured to obtain physiological measurements of the patient via the sensing element, determine at least one physiological parameter based on the physiological measurement, compare the at least one physiological parameter to a predetermined threshold, and, based on the comparison, provide an indication of the patient's health.

An improved, injection or blood removal device for intravenous access has a port with a septum at the exterior end of an intravenous catheter, a coupling element having an adhesive surface for securing attachment onto the skin, an injection or blood sampling unit, a connecting cannula piercing the septum of the port, and means to secure functional assembly. Attachment of the device to the skin covering or close to the intravenous puncture site and without long communicating tubes allows ambulant injection of drugs or measuring of concentration-time profiles of exogenous and endogenous analytes to improve treatment modalities on an individualized basis.

Methods and apparatus provide a therapeutic fluid to devices implanted in the body, for example to containers of devices implanted in the eye of a patient. The methods and apparatus may comprise an injector to increase an amount of therapeutic agent injected into the device implanted in the eye, or a structure to receive the therapeutic fluid within the device implanted in the eye, or combinations thereof. The device implanted in the eye may comprise a reservoir chamber having a fluid with a density different than the therapeutic fluid, and the apparatus can be adapted to at least partially separate the implanted device fluid from therapeutic fluid within the reservoir chamber to increase and amount of therapeutic fluid placed in the reservoir chamber.

The present disclosure provides apparatus and method for treating tension pneumothorax by using a rapid deployment chest port. The rapid deployment chest port can penetrate a patient's body to access a distressed pleural space. The rapid deployment chest port may create an airtight seal between the inside and outside of the patient's body and, when expanded, allow air or fluid to flow in one direction from inside the body to outside the body.

Dural repair devices that are configured to effectively and reliably repair the damage of a dural tear due to incidental durotomies are provided, along with methods of use. The devices and methods enhance the ability of a surgeon to repair a patent's dura mater, or dura, during surgery of the central nervous system. The dural repair device has a multi-layer structure configured to exert a pressure or tamponade effect to compress a patient's dura to its state prior to the spinal surgery. Thus, the dural repair devices and methods of use may reduce the patient's risk morbidity, further surgery, spinal headaches, or other injuries and discomforts.